Unknown

Dataset Information

0

Are we done with dose-intense temozolomide in recurrent glioblastoma?

ABSTRACT:

SUBMITTER: van den Bent MJ 

PROVIDER: S-EPMC4136902 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Are we done with dose-intense temozolomide in recurrent glioblastoma?

van den Bent Martin J MJ   Taal Walter W  

Neuro-oncology 20140725 9

Similar Datasets

Unknown Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study.
| S-EPMC6899067 | biostudies-literature
Unknown Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.
| S-EPMC4203514 | biostudies-literature
Unknown Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.
| S-EPMC3816958 | biostudies-literature
Unknown Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case report.
| S-EPMC4741824 | biostudies-literature
Unknown Detection of temozolomide-induced hypermutation and response to PD-1 checkpoint inhibitor in recurrent glioblastoma.
| S-EPMC9252128 | biostudies-literature
Unknown Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma.
| S-EPMC7139851 | biostudies-literature
Unknown Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma.
| S-EPMC3548585 | biostudies-literature
Unknown Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma.
| S-EPMC11913579 | biostudies-literature
Unknown Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation.
| S-EPMC10166157 | biostudies-literature
Unknown Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.
| S-EPMC7034757 | biostudies-literature